Scholarlink

Background <p>Critical illnesses such as sepsis, trauma, and multi-organ failure initiate complex molecular cascades that disrupt cellular homeostasis and contribute to poor outcomes. Key among these mediators are Nicotinamide Adenine Dinucleotide (NAD+/NADH), Nitric Oxide (NO), and Hypoxia-Inducible Factor 1-alpha (HIF1α), each playing crucial roles in redox regulation, immune modulation, and tissue adaptation to hypoxia.</p> Review <p>This review examines the individual and interrelated roles of NAD+, NO, and HIF1α in critically ill patients. We explore how imbalances in NAD+/NADH ratio impair mitochondrial metabolism, how dysregulated NO signaling alters vascular tone and immune responses, and how HIF1α stabilization governs transcriptional programs under hypoxia. By mapping the biochemical crosstalk among these molecules, we identify potential feedback loops that influence inflammation, cellular energetics, and patient outcomes. A central theme is the safety and therapeutic relevance of modulating these mediators, with specific focus on the timing, context, and molecular profile of patients in critical care.</p> Conclusion <p>Understanding the dynamic interplay among NAD+, NO, and HIF1α offers new opportunities for precision medicine in critical illness. We propose a hypothesis that phase-specific modulation of these pathways—through NAD+ precursors, NO donors/scavengers, or HIF1α stabilizers—could improve outcomes if guided by real-time molecular profiling. Prioritizing patient safety through targeted, biomarker-informed interventions may prevent progression to multi-organ failure and enable more personalized and effective treatments.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hypoxia-Inducible Factor 1-alpha (HIF1α), Nicotinamide Adenine Dinucleotide (NAD+, NADH), and Nitric Oxide (NO) interplay in critically ill patients, with implications for patient safety and targeted therapies: a review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月27日

查看全文
  • David Bar-Or,
  • Kaysie Banton,
  • David Acuna,
  • Jason Williams,
  • Carlos H. Palacio,
  • Charles W. Mains,
  • Raymond Garrett

摘要

Background

Critical illnesses such as sepsis, trauma, and multi-organ failure initiate complex molecular cascades that disrupt cellular homeostasis and contribute to poor outcomes. Key among these mediators are Nicotinamide Adenine Dinucleotide (NAD+/NADH), Nitric Oxide (NO), and Hypoxia-Inducible Factor 1-alpha (HIF1α), each playing crucial roles in redox regulation, immune modulation, and tissue adaptation to hypoxia.

Review

This review examines the individual and interrelated roles of NAD+, NO, and HIF1α in critically ill patients. We explore how imbalances in NAD+/NADH ratio impair mitochondrial metabolism, how dysregulated NO signaling alters vascular tone and immune responses, and how HIF1α stabilization governs transcriptional programs under hypoxia. By mapping the biochemical crosstalk among these molecules, we identify potential feedback loops that influence inflammation, cellular energetics, and patient outcomes. A central theme is the safety and therapeutic relevance of modulating these mediators, with specific focus on the timing, context, and molecular profile of patients in critical care.

Conclusion

Understanding the dynamic interplay among NAD+, NO, and HIF1α offers new opportunities for precision medicine in critical illness. We propose a hypothesis that phase-specific modulation of these pathways—through NAD+ precursors, NO donors/scavengers, or HIF1α stabilizers—could improve outcomes if guided by real-time molecular profiling. Prioritizing patient safety through targeted, biomarker-informed interventions may prevent progression to multi-organ failure and enable more personalized and effective treatments.